The short version
4 companies supply this market — a reasonable cushion if one runs into trouble. It is in shortage right now — FDA lists the reason as “other”.
Market view
lidocaine hydrochloride anhydrous
8 marketed package NDCs · 4 active manufacturers
Same drug class
Other molecules FDA puts in Amide Local Anesthetic, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
- bupivacaine hydrochloride in dextrose· in shortage
- bupivacaine hydrochloride and epinephrine· in shortage
- lidocaine hydrochloride anhydrous and dextrose monohydrate· in shortage
- bupivacaine hydrochloride and epinephrine bitartrate· in shortage
- lidocaine hydrochloride,epinephrine bitartrate· in shortage
- lidocaine hydrochloride and epinephrine· in shortage
- bupivacaine· in shortage
- ropivacaine hydrochloride· in shortage
- bupivacaine hydrochloride· in shortage
- lidocaine hydrochloride· in shortage
- lidocaine· in shortage
- 0.25% bupivacaine hcl· 1 maker
Common questions
- Is Lidocaine hydrochloride anhydrous in shortage right now?
- Yes. FDA currently lists Lidocaine hydrochloride anhydrous in shortage, with the reason given as "other". This page is rebuilt every morning from FDA's shortage database.
- Who makes Lidocaine hydrochloride anhydrous?
- 4 companies have marketed Lidocaine hydrochloride anhydrous in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
Shortage reports for this molecule
- In shortage now — Lidocaine Hydrochloride, Injection, 10 mg/1 mL (NDC 65282-1605-1)Jun 14, 2018
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.